Investing-News.Com
Information for Investors

DR. REDDY'S LAB L, (RDY) Stock Research - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

DR. REDDY'S LAB L, (RDY) Stock Research Free Stock Rating

 
Company Profile
 
Dr. Reddy’s Laboratories Limited engages in the development, manufacture, and marketing of pharmaceutical products in India and overseas. It offers active pharmaceutical ingredients, finished dosage forms, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular diseases, inflammation, and bacterial infection. Its principal areas of operations comprise formulations; active pharmaceutical ingredients and intermediates; diagnostics, critical care, and biotechnology; generics; drug discovery; and others. The company primarily operates in India, the United States, Russia, Brazil, Venezuela, Vietnam, Sri Lanka, Myanmar, and Trinidad. The company has strategic alliances with Par Pharmaceuticals, Inc.; Leiner Health Products, LLC; Cobalt Pharmaceuticals, Inc.; and Pharmascience, Inc. Dr. Reddy’s Laboratories was founded by K. Anji Reddy in 1984. The company is headquartered in Hyderabad, India.

DR. REDDY'S LAB L Related

Dr Reddy's Laboratories Limited Manufacturer of bulk drugs, intermediates, and formalutions.
Dr. Reddy's Laboratories - Wikipedia, the free encyclopedia Dr. Anji Reddy had worked in the publicly-owned Indian Drugs and Pharmaceuticals ... Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon ...
Dr. Reddy's Laboratories: Information from Answers.com Dr. Reddy's Laboratories Limited (NYSE:RDY) Company Financials Income Statement Balance Sheet Cash Flow Statement Contact Information Dr
Sponsored Links:

Software Forces DR. REDDY'S LAB L Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in DR. REDDY'S LAB L buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on DR. REDDY'S LAB L. This software is specially designed to give precision entry and exit points on DR. REDDY'S LAB L, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When DR. REDDY'S LAB L Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even DR. REDDY'S LAB L, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: google earnings expectations 2005  elegant bedsets  ubs indian equity analysis 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Dr. Reddy's launches generic migraine drug (AP)

Dr. Reddys Launches Authorized Generic Version of Imitrex®* Tablets (Business Wire)

Study shows Crestor cuts heart-attack risk, AstraZeneca says (at MarketWatch)

Q2 08/2009 Dr. Reddy's Laboratories Ltd. Earnings Release - Time Not Supplied (CCBN)

Dr. Reddy's Q2 FY09 Revenue at Rs. 16,151 Million, EBITDA at Rs. 2,746 Million, PAT at Rs. 1,212 Million (Business Wire)

Biotech Stocks: Drug stocks head south while Pfizer, Schering-Plough go north (at MarketWatch)

Biotech Stocks: Drug stocks cruise ahead with broader market (at MarketWatch)

Biotech Stocks: Drug stocks move forward with broader market (at MarketWatch)

India's Growth Story Interrupted (at Seeking Alpha)

Biotech Stocks: Drug shares gain steam as broad market sputters (at MarketWatch)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.